BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31962101)

  • 1. MicroRNA-708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt/β-catenin pathway.
    Yang J; Tao Q; Zhou Y; Chen Q; Li L; Hu S; Liu Y; Zhang Y; Shu J; Zhang X; Zhang L; Zhang L
    Eur J Pharmacol; 2020 Mar; 871():172927. PubMed ID: 31962101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F; Fan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway.
    Li LY; Yang CC; Yang JF; Li HD; Zhang BY; Zhou H; Hu S; Wang K; Huang C; Meng XM; Zhou H; Zhang L; Li J; Xu T
    Eur J Pharmacol; 2019 Dec; 865():172787. PubMed ID: 31712061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
    Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
    Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-145 induces the senescence of activated hepatic stellate cells through the activation of p53 pathway by ZEB2.
    Yang J; Lu Y; Yang P; Chen Q; Wang Y; Ding Q; Xu T; Li X; Li C; Huang C; Meng X; Li J; Zhang L; Wang X
    J Cell Physiol; 2019 May; 234(5):7587-7599. PubMed ID: 30479019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
    Sun J; Zhang H; Li L; Yu L; Fu L
    Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of hepatic stellate cell activation and liver fibrosis by microRNA-33a-5p through targeting the Dickkopf-1-mediated wingless-related integration site/beta-catenin pathway.
    Liu H; Zhang S; Li Z; Zheng Z; Shi W; Hu M; Liu F
    J Physiol Pharmacol; 2023 Aug; 74(4):. PubMed ID: 37865960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway.
    Li LY; Yang JF; Rong F; Luo ZP; Hu S; Fang H; Wu Y; Yao R; Kong WH; Feng XW; Chen BJ; Li J; Xu T
    Acta Pharmacol Sin; 2021 Oct; 42(10):1676-1689. PubMed ID: 33514855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.
    Xu T; Pan L; Li L; Hu S; Zhou H; Yang C; Yang J; Li H; Liu Y; Meng X; Li J
    J Cell Mol Med; 2020 Jul; 24(13):7127-7140. PubMed ID: 32463570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
    Feili X; Wu S; Ye W; Tu J; Lou L
    Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.